54m
Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations
Oral presentation features open label extension PALSONIFYâ„¢ (paltusotine) data, reinforcing its best-in-class potential in acromegaly following recent U.S. and E.U. approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results